Follow

• 

  Multidisciplinary Care for Adult Hermansky-Pudlak Syndrome Patients in Puerto Rico

  Isabel Becerra, Shirley Martinez, Atencio Xavier, Torrens Jonathan, Juan Alemany, Eric Cruz, Felix Rivera Borges, Monica Egozcue, Jesse Roman, and Rosa Roman

  Background: Hermansky-Pudlak syndrome (HPS) is an autosomal recessive rare disease characterized by oculo-cutaneous albinism, bleeding diathesis due to platelet dysfunction, and is sometimes accompanied by immunodeficiency, granulomatous colitis, and/or interstitial lung disease / pulmonary fibrosis. Puerto Rico houses the highest concentration of patients with HPS, especially HPS-1, which is considered quite severe and often associated with pulmonary fibrosis. We believe that the establishment of an HPS Multidisciplinary Clinic in Puerto Rico would improve outcomes.

  Methods: A multidisciplinary clinic was started in November 2018 and another was held in February 2019 at the Mayaguez Medical Center located in the Southwest region of the island. Pulmonologists, hematologists as well as gastroenterologists and a dentist staffed the clinic. Pulmonary function testing was available. Patients were identified by the HPS Network and other announcements.

  Results: Thirty-six patients were evaluated during the February 2019 clinic. Gender distribution was essentially equal and most patients were 50 years of age or younger. Fifty-eight percent classified themselves as having HPS-1 and 11% as having HPS-3, but the exact mutation was not known in 31%. Of the thirty patients obtaining pulmonary function tests, 60% showed abnormal force vital capacity (FVC) with 13% showing severe dysfunction. Thirty-one percent of patients had been treated for colitis, while 58% had bleeding at some point. Most patients had not received Influenza vaccination.

• 

  The Role of Diagnostic Bronchoscopy in Refractory Asthma Management

  Christopher McGrath, MD; Tuhina Raman, MD; and Jessica Most, MD

  Refractory asthma is an uncommon entity, manifesting in less than five percent of asthmatics and characterized by high medication requirements, persistent symptoms, frequent exacerbations, and significant airflow obstruction despite standard medical therapy.[1] Bronchoscopy may be an effective tool for identifying refractory asthma phenotypes.[3] The objective of this case series is to demonstrate the use of bronchoscopy to personalize treatment among a population of refractory asthmatics.

• 

  The In Vivo Effects of Alcohol in Lung and Liver are at Least Partially Mediated through the Alpha 4 Nicotinic Acetylcholine Receptor

  J. Ritzenthaler, E. Torres-Gonzalez, G. E. Arteel, and J. Roman

  Rational: Chronic alcohol abuse is a major risk factor for the development of acute lung injury, with 40% of annual cases in the U.S. linked to this disorder. Alcohol is not only associated with increased incidence of acute lung injury in at-risk individuals, but also increased mortality. The exact mechanisms by which alcohol abuse renders the host susceptible to acute lung injury remain poorly defined. We have reported that α4 nicotinic acetylcholine receptors (α4 nAChRs) may serve as potential sensors for alcohol in lung fibroblasts; however, we have not tested their role in vivo.

  Methods: To test the role of α4 nAChRs in mediating alcohol-related events in vivo, we generated α4 nAChR knockout (KO) animals in C57Bl/6 using Crispr/Cas technology. Wildtype (WT) and α4 nAChR knockout (α4 KO) animals were used to harvest primary lung fibroblasts for study in vitro. In vivo experiments included exposure to Lieber DeCarli isocaloric or Maltose-Dextrin control diet for 6 weeks.

  Results: Having ensured that the α4 KO animals indeed lacked the α4 nAChR, we isolated primary lung fibroblasts and evaluated their expression of the matrix glycoprotein fibronectin after exposure to nicotine (50 ug/ml) or alcohol (60 mM). As expected, nicotine induced fibronectin expression independent of the presence or absence of α4 nAChRs. In contrast, alcohol induced fibronectin mRNA expression in primary lung fibroblasts harvested from WT animals, but not from α4 KO animals. We then engaged in in vivo studies designed to examine the expression of specific genes in whole lung and liver; including the cysteine transporter Slc7a11 (which controls redox state), the pro-inflammatory cytokine TNFα (which has been implicated in alcohol-induced lung injury), and the protease inhibitor PAI-1, (which also appears involved in alcohol-related injury to lung and liver). No overt structural abnormalities were detected in the α4 KO animals. After 6 weeks of control or alcohol diets, lungs and livers were harvested and processed for mRNA evaluation. WT lungs and livers showed significant induction of all three mRNAs when exposed to alcohol, whereas the α4 KO animals showed little to no induction. Liver histology also showed evidence of increased steatosis in WT animals when compared to the α4 KO animals.